Use of modeling in the study of economic burden of influenza in the elderly population in Central and Eastern European countries

The economic burden of the incidence of influenza and ARI requires careful study, since annually about 15% of the world's population suffers from these diseases. In addition, the flu can cause complications that are dangerous to human life and health, especially those at risk. The elderly popul...

Full description

Bibliographic Details
Main Author: M. V. Leleka
Format: Article
Language:Ukrainian
Published: The State Expert Center of the Ministry of Health of Ukraine 2018-08-01
Series:Фармацевтичний журнал
Subjects:
Online Access:https://pharmj.org.ua/index.php/journal/article/view/28/25
id doaj-43be9e3d87664d0189700d275691b105
record_format Article
spelling doaj-43be9e3d87664d0189700d275691b1052020-11-25T00:12:53ZukrThe State Expert Center of the Ministry of Health of UkraineФармацевтичний журнал0367-30572617-96282018-08-01(3-4)344210.32352/0367-3057.3-4.17.04Use of modeling in the study of economic burden of influenza in the elderly population in Central and Eastern European countriesM. V. Leleka0Danylo Halytsky Lviv National Medical UniversityThe economic burden of the incidence of influenza and ARI requires careful study, since annually about 15% of the world's population suffers from these diseases. In addition, the flu can cause complications that are dangerous to human life and health, especially those at risk. The elderly population belongs precisely to this group, therefore we have chosen to analyze the economic burden of this category of population. According to the international classification, this group of diseases is divided into the following types: Influenza-like illness (ILI); – Acute respiratory infection (ARI); – Severe acute respiratory infections (SARI); – Severe Acute Respiratory Syndrome (SARS). The aim of the work was to develop a model for systematization flows of patients and treatment costs in assessing the economic burden of influenza and ARI morbidity in the elderly peoples in Central and Eastern Europe. The model was developed in cooperation with the Syreon Institute, Hungary. The study involved Hungary, Poland, the Czech Republic, Romania, Ukraine and Kazakhstan. The structure of the model is based on the assumption of a flow of patients. The principle of the model was as follows: in order to assess the economic burden of the disease in a certain period of time, it is necessary to quantify (1) the number of patients, and (2) the costs of health care and treatment. The cost of treatment is different in each case, patients should be divided into relatively homogeneous groups. Since the quantity and quality of the epidemiological data on influenza and related diseases is rather heterogeneous in different countries, WHO offers certain objects of influenza research, taken as a basis for constructing such a model. According to this classification of influenza and WHO definition, the central structure of our model was formed by acute respiratory infections (ARI), representing outpatient cases and severe acute respiratory infections (SARI), representing inpatient cases. The next stage of the research was the study of the cost structure and the principles of collecting expenditure data. The economic burden of influenza in the elderly populations has been analyzed based on the type of health system. In older people, it is difficult to establish a link between influenza and complications of chronic diseases and other acute medical conditions (eg, acute coronary syndrome). This analysis does not include estimates of the economic impact of influenza on other co-morbidities and long-term chronic effects associated with complications of influenza. Since the population of 60+ or 65+ is a risk group and is a numerical group, the cost of treatment in the event of complications and hospitalization will increase cost for the patient and for the medical institution. However, in this case indirect costs is missing, such as paying a sick list. Direct medical cost were subject to analysis. The proposed methodology allows you to objectively assess the costs of treatment and calculate the economic burden, taking into account the type and health system.https://pharmj.org.ua/index.php/journal/article/view/28/25influenza and ARImorbidityelderly populationexpenseseconomic burden
collection DOAJ
language Ukrainian
format Article
sources DOAJ
author M. V. Leleka
spellingShingle M. V. Leleka
Use of modeling in the study of economic burden of influenza in the elderly population in Central and Eastern European countries
Фармацевтичний журнал
influenza and ARI
morbidity
elderly population
expenses
economic burden
author_facet M. V. Leleka
author_sort M. V. Leleka
title Use of modeling in the study of economic burden of influenza in the elderly population in Central and Eastern European countries
title_short Use of modeling in the study of economic burden of influenza in the elderly population in Central and Eastern European countries
title_full Use of modeling in the study of economic burden of influenza in the elderly population in Central and Eastern European countries
title_fullStr Use of modeling in the study of economic burden of influenza in the elderly population in Central and Eastern European countries
title_full_unstemmed Use of modeling in the study of economic burden of influenza in the elderly population in Central and Eastern European countries
title_sort use of modeling in the study of economic burden of influenza in the elderly population in central and eastern european countries
publisher The State Expert Center of the Ministry of Health of Ukraine
series Фармацевтичний журнал
issn 0367-3057
2617-9628
publishDate 2018-08-01
description The economic burden of the incidence of influenza and ARI requires careful study, since annually about 15% of the world's population suffers from these diseases. In addition, the flu can cause complications that are dangerous to human life and health, especially those at risk. The elderly population belongs precisely to this group, therefore we have chosen to analyze the economic burden of this category of population. According to the international classification, this group of diseases is divided into the following types: Influenza-like illness (ILI); – Acute respiratory infection (ARI); – Severe acute respiratory infections (SARI); – Severe Acute Respiratory Syndrome (SARS). The aim of the work was to develop a model for systematization flows of patients and treatment costs in assessing the economic burden of influenza and ARI morbidity in the elderly peoples in Central and Eastern Europe. The model was developed in cooperation with the Syreon Institute, Hungary. The study involved Hungary, Poland, the Czech Republic, Romania, Ukraine and Kazakhstan. The structure of the model is based on the assumption of a flow of patients. The principle of the model was as follows: in order to assess the economic burden of the disease in a certain period of time, it is necessary to quantify (1) the number of patients, and (2) the costs of health care and treatment. The cost of treatment is different in each case, patients should be divided into relatively homogeneous groups. Since the quantity and quality of the epidemiological data on influenza and related diseases is rather heterogeneous in different countries, WHO offers certain objects of influenza research, taken as a basis for constructing such a model. According to this classification of influenza and WHO definition, the central structure of our model was formed by acute respiratory infections (ARI), representing outpatient cases and severe acute respiratory infections (SARI), representing inpatient cases. The next stage of the research was the study of the cost structure and the principles of collecting expenditure data. The economic burden of influenza in the elderly populations has been analyzed based on the type of health system. In older people, it is difficult to establish a link between influenza and complications of chronic diseases and other acute medical conditions (eg, acute coronary syndrome). This analysis does not include estimates of the economic impact of influenza on other co-morbidities and long-term chronic effects associated with complications of influenza. Since the population of 60+ or 65+ is a risk group and is a numerical group, the cost of treatment in the event of complications and hospitalization will increase cost for the patient and for the medical institution. However, in this case indirect costs is missing, such as paying a sick list. Direct medical cost were subject to analysis. The proposed methodology allows you to objectively assess the costs of treatment and calculate the economic burden, taking into account the type and health system.
topic influenza and ARI
morbidity
elderly population
expenses
economic burden
url https://pharmj.org.ua/index.php/journal/article/view/28/25
work_keys_str_mv AT mvleleka useofmodelinginthestudyofeconomicburdenofinfluenzaintheelderlypopulationincentralandeasterneuropeancountries
_version_ 1725396928650280960